Investigation of a novel brachytherapy ureteral stent: trial studies on normal beagle dogs.

Purpose: To evaluate the safety and feasibility of a newly designed ¹²⁵I brachytherapy ureteral stent (BUS) in normal dogs. Methods: A BUS loaded with 10 ¹²⁵I seeds (Group A: 0.8 mCi, Group B: 0.4 mCi, Group C: 0 mCi) was designed and tested in 27 normal beagle dogs. Routine blood tests, gross observations, cumulative radiation doses, tissue reaction assessed by hematoxylin–eosin/Masson staining, mRNA analysis by RT-qPCR and protein expression of Caspase-3, Collagen I, PCNA, and α-SMA were performed at 2, 4 and 8 weeks. Results: The BUS was implanted successfully in all dogs (27/27) without surgery-related death. The ureter diameter and radiation injury score increased along with radiation accumulation (p < 0.05). Histopathologic analysis showed necrotic tissue and lateral fibrosis to different extents in the ureteral walls that gradually increased in all groups (p < 0.05); however, epithelial cell proliferation in groups A and B was lighter than that in the control group (p < 0.05). Conclusion: Placement of the newly designed ¹²⁵I BUS was safe and feasible in dogs, and clinical studies are required to test its use in humans. [ABSTRACT FROM AUTHOR]